featured
Phase II Clinical Trial of Amatuximab in Advanced Pleural Mesothelioma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Clinical Trial of Amatuximab, a Chimeric Antimesothelin Antibody With Pemetrexed and Cisplatin in Advanced Unresectable Pleural Mesothelioma
Clin. Cancer Res 2014 Dec 01;20(23)5927-5936, R Hassan, HL Kindler, T Jahan, L Bazhenova, M Reck, A Thomas, I Pastan, J Parno, DJ O'Shannessy, P Fatato, JD Maltzman, BA WallinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.